KNAW

Research

A double-blind, randomized, parallel group, placebo controlled, sequential...

Pagina-navigatie:


Update content


Title A double-blind, randomized, parallel group, placebo controlled, sequential dose escalation study of anti-MCP-1 therapy in patients with rheumatoid arthritis
Period 01 / 2003 - unknown
Status Completed
Research number OND1294007
Data Supplier Aangemeld door projectleider

Related organisations

Related people

Project leader Prof.dr. P.P. Tak

Classification

D23210 Dermatology, venereology, rheumatology, orthopedics
D23340 Biopharmacology, toxicology

Go to page top
Go back to contents
Go back to site navigation